Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Asthma Programme in Finland: Did the use of secondary care resources become more rational?

Tuomisto LE, Erhola M, Luukkaala T, Puolijoki H, Nieminen MM, Kaila M.

Respir Med. 2010 Jul;104(7):957-65. doi: 10.1016/j.rmed.2010.01.018. Epub 2010 Mar 5.

2.

Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD).

Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T, Lindberg E, Brøndum E, Aine T, Bakke P, Janson C.

Respir Med. 2007 Sep;101(9):1954-60. Epub 2007 May 25.

3.

Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity.

Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P, Janson C.

Respir Res. 2006 Aug 16;7:109.

4.

A 10 year asthma programme in Finland: major change for the better.

Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, Nieminen MM, Kontula E, Laitinen LA.

Thorax. 2006 Aug;61(8):663-70.

5.

Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression.

Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P.

Eur Respir J. 2005 Sep;26(3):414-9.

6.

Childhood cat exposure-related tolerance is associated with IL1A and IL10 polymorphisms.

Karjalainen J, Virta M, Pessi T, Hulkkonen J, Nieminen MM, Hurme M.

J Allergy Clin Immunol. 2005 Jul;116(1):223-5. No abstract available.

PMID:
15990800
7.

Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries.

Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli Ulrik C, Brøndum E, Nieminen MM, Aine T, Hallin R, Bakke P.

Respir Med. 2006 Jan;100(1):87-93.

8.

Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area.

Rajalahti I, Ruokonen EL, Kotomäki T, Sintonen H, Nieminen MM.

Eur Respir J. 2004 Mar;23(3):446-51.

9.

Allergic rhinitis and polymorphisms of the interleukin 1 gene complex.

Joki-Erkkilä VP, Karjalainen J, Hulkkonen J, Pessi T, Nieminen MM, Aromaa A, Klaukka T, Hurme M.

Ann Allergy Asthma Immunol. 2003 Sep;91(3):275-9.

PMID:
14533660
10.

The IL1A genotype is associated with nasal polyposis in asthmatic adults.

Karjalainen J, Joki-Erkkilä VP, Hulkkonen J, Pessi T, Nieminen MM, Aromaa A, Klaukka T, Hurme M.

Allergy. 2003 May;58(5):393-6.

PMID:
12752325
11.

A common IL-1 complex haplotype is associated with an increased risk of atopy.

Pessi T, Karjalainen J, Hulkkonen J, Nieminen MM, Hurme M.

J Med Genet. 2003 May;40(5):e66. No abstract available.

12.

Adulthood mortality of infants isolated at birth due to tuberculosis in the family.

Veijola JM, Mäki PH, Joukamaa MI, Läärä E, Hakko H, Nieminen MM, Isohanni MK.

Scand J Public Health. 2003;31(1):69-72.

PMID:
12623528
13.
14.

No impairment of peripheral deposition in novel asthmatics treated with an MDI corticosteroid with spacer.

Saari SM, Vidgren MT, Turjanmaa VM, Koskinen MO, Nieminen MM.

Respir Med. 2003 Feb;97(2):152-8.

15.

Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma.

Karjalainen J, Hulkkonen J, Nieminen MM, Huhtala H, Aromaa A, Klaukka T, Hurme M.

Clin Exp Allergy. 2003 Jan;33(1):78-83.

PMID:
12534553
16.

Possibilities of formoterol to enhance the peripheral lung deposition of the inhaled liposome corticosteroids.

Saari SM, Vidgren MT, Herrala J, Turjanmaa VM, Koskinen MO, Nieminen MM.

Respir Med. 2002 Dec;96(12):999-1005.

17.

The IL1A genotype associates with atopy in nonasthmatic adults.

Karjalainen J, Hulkkonen J, Pessi T, Huhtala H, Nieminen MM, Aromaa A, Klaukka T, Hurme M.

J Allergy Clin Immunol. 2002 Sep;110(3):429-34.

PMID:
12209090
18.

The IL-1beta genotype carries asthma susceptibility only in men.

Karjalainen J, Nieminen MM, Aromaa A, Klaukka T, Hurme M.

J Allergy Clin Immunol. 2002 Mar;109(3):514-6.

PMID:
11898000
19.

The efficacy of a new salbutamol metered-dose powder inhaler in comparison with two other inhaler devices.

Seppälä OR, Aalto E, Annila, Hakonen T, Lukkari-Lax E, Jouhikainen T, Nieminen MM, Liipp K.

Respir Med. 2001 Dec;95(12):949-53.

20.

Evaluation of commercial DNA and rRNA amplification assays for assessment of treatment outcome in pulmonary tuberculosis patients.

Rajalahti I, Vuorinen P, Liippo K, Nieminen MM, Miettinen A.

Eur J Clin Microbiol Infect Dis. 2001 Oct;20(10):746-50.

PMID:
11757980
21.

Increase of asthma in adults in northern Finland?--a report from the FinEsS study.

Kotaniemi JT, Lundbäck B, Nieminen MM, Sovijärvi AR, Laitinen LA.

Allergy. 2001 Feb;56(2):169-74.

PMID:
11167379
22.

Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler.

Bousquet J, D'Urzo A, Hebert J, Barraza CH, Boulet LP, Suárez-Chacón R, Harnest U, Lundbäck B, Martinez Morales G, Nieminen MM, Nolop KB, Visser S, Lutsky BN.

Eur Respir J. 2000 Nov;16(5):808-16.

23.

Bee venom induces high histamine or high leukotriene C4 release in skin of sensitized beekeepers.

Annila I, Saarinen JV, Nieminen MM, Moilanen E, Hahtola P, Harvima IT.

J Investig Allergol Clin Immunol. 2000 Jul-Aug;10(4):223-8.

PMID:
11039839
24.

Association between apolipoprotein E alleles and autoantibodies against oxidised low-density lipoprotein.

Saarelainen S, Lehtimäki T, Nikkilä M, Solakivi T, Nieminen MM, Jaakkola O.

Clin Chem Lab Med. 2000 May;38(5):477-8. No abstract available.

PMID:
10952232
25.

Serum ECP and MPO, but not urinary LTE4, are associated with bronchial hyper-responsiveness.

Hedman J, Moilanen E, Poussa T, Nieminen MM.

Respir Med. 1999 Aug;93(8):589-96.

26.

Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study.

Hedman J, Kaprio J, Poussa T, Nieminen MM.

Int J Epidemiol. 1999 Aug;28(4):717-22.

PMID:
10480701
27.

Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea.

Saarelainen S, Lehtimäki T, Jaak-kola O, Poussa T, Nikkilä M, Solakivi T, Nieminen MM.

Clin Chem Lab Med. 1999 May;37(5):517-20.

PMID:
10418741
28.

Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers.

Saari M, Vidgren MT, Koskinen MO, Turjanmaa VM, Nieminen MM.

Int J Pharm. 1999 Apr 20;181(1):1-9.

PMID:
10370197
29.

Human plasma antioxidant capacity during radiotherapy for lung cancer: a clinical study.

Erhola M, Nieminen MM, Ojala A, Metsä-Ketelä T, Kellokumpu-Lehtinen P, Alho H.

J Exp Clin Cancer Res. 1998 Sep;17(3):325-30.

PMID:
9894770
30.

A new beclomethasone dipropionate multidose powder inhaler in the treatment of bronchial asthma.

Nieminen MM, Vidgren P, Kokkarinen J, Laasonen K, Liippo K, Lindqvist A, Paananen M, Poukkula A, Ruotsalainen E, Salomaa E, Sovijärvi A, Söderblom T, Silvasti M, Vidgren M, Laitinen LA.

Respiration. 1998;65(4):275-81.

PMID:
9730793
31.

Effects of surgical removal of lung cancer on total plasma antioxidant capacity in lung cancer patients.

Erhola M, Nieminen MM, Kellokumpu-Lehtinen P, Huusari H, Alanko K, Metsä-Ketelä T, Alho H.

J Exp Clin Cancer Res. 1998 Jun;17(2):219-25.

PMID:
9700584
32.

The bronchoprotective efficacy of salbutamol inhaled from a new metered-dose powder inhaler compared with a conventional pressurized metered-dose inhaler connected to a spacer.

Seppälä OP, Herrala J, Hedman J, Alanko K, Liipo K, Terho E, Pietinalho A, Nyholm JE, Nieminen MM.

Respir Med. 1998 Mar;92(3):578-83.

33.

Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma.

Saari SM, Vidgren MT, Koskinen MO, Turjanmaa VM, Waldrep JC, Nieminen MM.

Chest. 1998 Jun;113(6):1573-9.

PMID:
9631796
34.

Lymphocyte subpopulations, cytokine release and specific immunoglobulin G in reactive and nonreactive beekeepers.

Annila I, Hurme M, Miettinen A, Kuusisto P, Nieminen MM.

J Investig Allergol Clin Immunol. 1998 Mar-Apr;8(2):109-14.

PMID:
9615305
35.

No relation between apolipoprotein E alleles and obstructive sleep apnea.

Saarelainen S, Lehtimäki T, Kallonen E, Laasonen K, Poussa T, Nieminen MM.

Clin Genet. 1998 Feb;53(2):147-8.

PMID:
9611077
36.

Clodronate is effective in preventing corticosteroid-induced bone loss among asthmatic patients.

Herrala J, Puolijoki H, Liippo K, Raitio M, Impivaara O, Tala E, Nieminen MM.

Bone. 1998 May;22(5):577-82.

PMID:
9600795
37.
39.

Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2'-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment.

Erhola M, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Uchida K, Osawa T, Nieminen MM, Alho H, Kellokumpu-Lehtinen P.

FEBS Lett. 1997 Jun 9;409(2):287-91.

40.

Plasma peroxyl radical trapping capacity in lung cancer patients: a case-control study.

Erhola M, Nieminen MM, Kellokumpu-Lehtinen P, Metsä-Ketelä T, Poussa T, Alho H.

Free Radic Res. 1997 May;26(5):439-47.

PMID:
9179589
41.
42.

Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patients.

Erhola M, Kellokumpu-Lehtinen P, Metsä-Ketelä T, Alanko K, Nieminen MM.

Free Radic Biol Med. 1996;21(3):383-90.

PMID:
8855450
43.

Asbestos-induced visceral pleural fibrosis reduces pulmonary compliance.

Valkila EH, Nieminen MM, Moilanen AK, Kuusisto PA, Lahdensuo AH, Karvonen JI.

Am J Ind Med. 1995 Sep;28(3):363-72.

PMID:
7485190
44.

Bimodal effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit.

Nieminen MM, Henson PM, Irvin CG.

Exp Lung Res. 1994 Nov-Dec;20(6):559-77.

PMID:
7882906
45.

Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate.

Herrala J, Puolijoki H, Impivaara O, Liippo K, Tala E, Nieminen MM.

Bone. 1994 Nov-Dec;15(6):621-3.

PMID:
7873290
46.

Easyhaler, a novel multiple dose powder inhaler: clinically equivalent to salbutamol metered dose inhaler and easier to use.

Nieminen MM, Vidgren M, Laurikainen K, Järvinen M, Liippo K, Tammivaara R, Silvasti M.

Respiration. 1994;61(1):37-41.

PMID:
8177971
47.

Measurement of respiratory muscle forces based on maximal inspiratory and expiratory pressures.

Karvonen J, Saarelainen S, Nieminen MM.

Respiration. 1994;61(1):28-31.

PMID:
8177969
48.

Interactions between synthesis of platelet-activating factor and leukotriene B4 in isolated human polymorphonuclear leukocytes.

Moilanen E, Kirkkola AL, Kankaanranta H, Nieminen MM, Vapaatalo H.

Inflammation. 1993 Dec;17(6):705-14.

PMID:
8112829
49.

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group.

Dahl R, Lundback B, Malo JL, Mazza JA, Nieminen MM, Saarelainen P, Barnacle H.

Chest. 1993 Nov;104(5):1352-8.

PMID:
8222787
50.

Attenuation of exercise induced asthma by local hyperthermia.

Nieminen MM.

Thorax. 1993 Apr;48(4):411. No abstract available.

Supplemental Content

Loading ...
Support Center